Access cutting-edge myasthenia gravis treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access myasthenia gravis specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myasthenia gravis treatment provided free
This is a 26-week study to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis.
Sponsor: Immunovant Sciences GmbH
Check if you qualify for this myasthenia gravis clinical trial in San Francisco, CA
If you're searching for myasthenia gravis treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myasthenia gravis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.